辛巴先生
Lv42
680 积分
2024-03-19 加入
-
Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review
1天前
待确认
-
Cytochrome P450 and Other Drug-Metabolizing Enzymes As Therapeutic Targets
3天前
已完结
-
Recent Advances in the Medicinal Chemistry of Farnesoid X Receptor
1个月前
已完结
-
De novo design of a peptide modulator to reverse sodium channel dysfunction linked to cardiac arrhythmias and epilepsy
1个月前
已完结
-
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
1个月前
已完结
-
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
2个月前
已完结
-
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
2个月前
已完结
-
Upgrading therapeutic ambitions and treatment outcomes
2个月前
已完结
-
Inflammatory bowel disease: classifying global regions by epidemiological stage
2个月前
已完结
-
Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?
2个月前
已完结